Navigation Links
Micromet Presents Update on Blinatumomab's Response Rate and Duration in a Phase 1 Study in Non-Hodgkin's Lymphoma Patients
Date:6/8/2009

that blinatumomab and BiTE antibodies, in general, may have in fighting cancer," said Micromet's Senior Vice President and Chief Medical Officer, Carsten Reinhardt, M.D.

(1) Klinger, M. et al. (2009). Pharmacodynamic analyses of peripheral blood from relapsed B-NHL patients treated with anti-CD19/-CD3 bispecific BiTE(R) antibody blinatumomab. 14th Congress of EHA, abstract number 430

(2) Bargou, R. et al. (2008). Sustained Response Duration Seen after Treatment with Single Agent Blinatumomab (MT103/MEDI-538) in the Ongoing Phase I Study MT103-104 in Patients with Relapsed NHL. ASH 2008, abstract number 267

Webcast/Conference Call

Micromet will host a webcast/conference call this morning from 9:00 am to 11:00 am U.S. Eastern time to discuss the blinatumomab data presented at the 14th Congress of the European Hematology Association. The webcast will be available on the company's website at www.micromet-inc.com. To participate in the conference call, dial 866-543-6403 (U.S.) or 617-213-8896 (international), passcode: 12594792.

A replay of the call will be available from 1:00 pm Eastern Time on June 8, 2009 (7:00 pm Central European Time) through June 15, 2009. The replay number is 888-286-8010 (U.S.) or 617-801-6888 (international), passcode: 67386852.

About Micromet, Inc.

Micromet, Inc. is a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel antibodies generated with its proprietary BiTE(R) antibody platform, as well as conventional monoclonal antibodies. BiTE antibodies represent a new class of antibodies that activate the T cells of a patient's immune system to eliminate cancer cells. Four of Micromet's antibodies are currently in clin
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day
2. Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells
3. Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203
4. Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients
5. Micromet Key Events for 2009
6. Micromet Expands Committed Equity Financing Facility to $75 Million
7. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
8. Micromet Presents Data at ESMO 2008 on Anti-EpCAM Antibody Adecatumumab (MT201) in Combination with Chemotherapy
9. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results
11. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)...  Celsion Corporation (NASDAQ: CLSN ), an oncology ... Tardugno , Chairman, President and CEO, is scheduled to ... Wednesday, July 8, 2015, at 4:15 p.m. Eastern Time. The ... located at 119 W. 56th Street, New ... of the presentation will be available in the Events ...
(Date:7/1/2015)... 2015 Radiant Insights announce that ... Concentrators Market Shares, Strategy, and Forecasts, Worldwide, 2015 ... growth as the aging population worldwide needs homecare oxygen ... where oxygen is able to improve the quality of ... become affordable and support a mobile lifestyle even while ...
(Date:7/1/2015)... July 1, 2015 New exchange plan enrollees ... 2015 compared to the same time a year ago, ... (NASDAQ: ESRX ) Exchange Pulse™ report, released today. ... 2014, the number of new exchange plan enrollees who ... in the first quarter of 2015. However, when evaluating ...
Breaking Medicine Technology:Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 2Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 5
... 30 London Genetics Limited, an expert in,the ... development, has,entered an intensive partnering programme following on ... recognised that while,pharmacogenetics and genetics have great potential ... early clinical,collaboration between companies, academia, regulators and payers ...
... FRANCISCO, Oct. 30 CCBR-SYNARC, the world,s leading provider ... center services to the pharmaceutical and biotechnology industries, announced ... for use in imaging clinical trials. , SYNARC has ... 2004. With the release of the enhanced SynarcConnect(SM) ...
Cached Medicine Technology:London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference 2London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference 3London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference 4CCBR-SYNARC Expands Electronic Data Capture Capabilities 2
(Date:7/1/2015)... Livonia, Mich. (PRWEB) , ... July 01, 2015 ... ... the transition of Catholic sponsorship complete, St. Joseph’s Health, located in Syracuse, N.Y., ... "With the closing today, we have gained an admirable and important partner committed ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... Biomedical Sciences at Georgia State University and a Georgia Research Alliance Eminent Scholar ... develop novel anti-inflammatory therapeutics against middle-ear infections. , The grant from the National ...
(Date:7/1/2015)... ... July 01, 2015 , ... Sir Fazle Hasan Abed, BRAC’s ... Prize today. Sir Fazle has been recognised for his outstanding contribution to enhancing the ... Ken Quinn, President of the World Food Prize Foundation, announced this year’s winner at ...
(Date:7/1/2015)... ... July 01, 2015 , ... The federal ... ( http://www.injurybeacon.com/levaquin/lawsuit/ ) has granted the Defendants’ Motion for Summary Judgment. According to ... on June 26th, the Court rejected the Plaintiff’s assertion that one manufacturer ...
(Date:7/1/2015)... New York, NY (PRWEB) , ... July 01, 2015 , ... ... around which DNA is wound, histones, remain constant in the brain, never changing after ... Sinai have discovered that histones are steadily replaced in brain cells throughout life – ...
Breaking Medicine News(10 mins):Health News:St. Joseph’s Health Now a Member of Trinity Health 2Health News:St. Joseph’s Health Now a Member of Trinity Health 3Health News:St. Joseph’s Health Now a Member of Trinity Health 4Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4
... Conference Foundation Prize in Pediatric, Oncology for Novel Approaches for ... ... SUNNYVALE, Calif., April 3, 2008 Xoft consulting,medical director, Mark ... Oncology for his research focused on novel,approaches for using KV X-ray-based ...
... Kelly Ripa Team Up to Promote New Appliance Line,s European, Style ... ... -, NEW YORK, April 3, 2008 Known and admired for ... is tapping Kelly Ripa for the North America launch of its new,premium ...
... within primary breast tumors can empower cells that break ... organs, researchers report in the April 4th Cell, a ... hundreds of human breast tumors, the researchers found evidence ... breast cancer cells for metastasis to the lungs, one ...
... Prenatal syphilis screening, recommended by the Centers ... health authorities, is critical to preventing still births ... mothers. A study published in the April ... that state Medicaid statistics, when used to determine ...
... Selective,Insurance Group, Inc. announced the following ... America ("Selective"):, Yanina Hupka (Sparrowbush, NY), ... she served as assistant vice president,and assistant ... 2000 as a,senior reinsurance accountant. Before coming ...
... and unstated feelings about Clinton, BOSTON, April 3, ... "insecure" than they are typically willing,to admit, according to ... "confidence" voters express about the U.S. Senator from New,York ... does not appear to be,very deep., Emotion Mining, ...
Cached Medicine News:Health News:Xoft Medical Director Recognized by Gotham Prize for Cancer Research 2Health News:Xoft Medical Director Recognized by Gotham Prize for Cancer Research 3Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 2Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 3Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 4Health News:Human breast tumors' 'microenvironment' primes them for metastasis 2Health News:Prenatal syphilis screening rates: Are they being accurately reported? 2Health News:Voting for Clinton Evokes Deep-Seated Feelings of Insecurity 2
... The ABL800 FLEX is a fully ... most advanced blood gas analyzer along ... gives you the freedom to focus ... FLEX provides features that are essential ...
Flatbed Agitator....
Flatbed Agitator....
... platelet agitators offer a wide range of ... the drawer storage platform to agitate smoothly, ... wear down and squeak. Sturdy, one-piece perforated ... air circulation for your platelets., ,i.Series platelet ...
Medicine Products: